Should blue chip investors love CSL (ASX:CSL) shares?
Jaz Harrison
January 10, 2021
CSL Limited (ASX:CSL) shares could be an interesting idea for
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) shares could be an interesting idea for
Looking for the best Australian shares ETFs of 2021? There
My top 5 ASX ETFs for a diversified portfolio: iShares
The S&P/ASX 200 (INDEXASX: XJO) is expected to open flat
CSL Limited (ASX:CSL) announced some disappointing UQ COVID-19 vaccine news
The S&P/ASX 200 (ASX: XJO) is expected to open slightly
The CSL Limited (ASX:CSL) share price could be in danger,
The S&P/ASX 200 (INDEXASX:XJO) is set to rise when (or
CSL Limited (ASX:CSL) is in the news this morning after
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
By downloading, you agree to receive emails from us. You can unsubscribe anytime.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.